2-Naphthylmethcathinone (BMAPN), also known as βk-methamnetamine, is a stimulant drug of the cathinone and naphthylaminopropane families. It inhibits dopamine reuptake and has rewarding and reinforcing properties in animal studies. It is banned under drug analogue legislation in a number of jurisdictions. The drug was at one point marketed under the name NRG-3, although only a minority of samples of substances sold under this name have been found to actually contain BMAPN, with most such samples containing mixtures of other cathinone derivatives.
+ Compound Ref d-Amphetamine 6.6–10.2 5.8–24.8 698–1,765 Naphthylaminopropane (NAP; PAL-287) 11.1 12.6 3.4 d-Methamphetamine 12.3–14.3 8.5–40.4 736–1,292 Methylnaphthylaminopropane (MNAP; PAL-1046) 34 10 13 l-Methcathinone 13.1 14.8 1,772 2-Naphthylmethcathinone (BMAPN; βk-MNAP) 94% at 10μM 34 27 d-Ethylamphetamine 28.8 44.1 333.0 Ethylnaphthylaminopropane (ENAP; PAL-1045) 137 46 a 12 a Phenmetrazine 29–50.4 70–131 7,765–>10,000 Naphthylmetrazine (PAL-704) 203 111 (105) Notes: The smaller the value, the more strongly the drug releases the neurotransmitter. The assays were done in rat brain synaptosomes and human potencies may be different. See also Monoamine releasing agent § Activity profiles for a larger table with more compounds. Footnotes: a is a partial releaser of serotonin ( = 66%) and dopamine ( = 78%). Refs:
See also 1-Naphthylmethcathinone (AMAPN) βk-Ephenidine Methamnetamine Methylnaphthidate Methylone Naphyrone WF-23
References